3 ms·
You are giving way too much credit to patents for the state of the pharmaceutical market. Even if you were given all of the relevant IP free and unrestricted i
by vonmoltke 10y ago
You are giving way too much credit to patents for the state of the pharmaceutical market. Even if you were given all of the relevant IP free and unrestricted it would still cost at least a couple hundred million to bring it to market, assuming you already have the facilities to create and manufacture the compound.
On top of that. things like "open source 3d printable epinephrine injector[s]" are a very dangerous pipe dream. While there is certainly regulatory capture involved, most of the regulations relating to development, manufacturing, and distribution of pharmaceuticals and medical devices are in place for good reasons.
- 2close4comfort 10y agoto the control the market...
- Ralfp 10y agoYes. Do you know what happens when drug market isn't controlled? You end with drugs that are roughtly what they are declared, but upon analysis turn to contain few percent of impurities that may be toxic or plainly fatal. This is everyday of illegal drug import from east to west in Europe, but thanks to Shengen EU's border saw some tightening in recent years, and so number of "cheaper alternative drugs" is at minimum these days.
- 2close4comfort 10y agoThis is the VERY problem with my solution. And one I have no good answer to. If I do find the answer though and you see this on the market think of me or the person smarter than me who figured this out.
- 2close4comfort 10y agoIP? really I would think that jabbing yourself with a needle and emptying a vial is pretty easy and probably could be done MUCH better than it is currently. Single use is wasteful why not make the system refillable and disabled after use.